Trial
NCT01201538
A Study of Nilotinib in Growing Vestibular Schwannomas
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
Novartis
Condition
Growing Vestibular Schwannomas
Intervention
Nilotinib
Why stopped
Study PI passed away We had trouble recruiting for the drug arm
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-11